DMH2 is a novel and potent antagonist of bone morphogenetic protein (BMP) type I receptor with Ki
values of <1, 5.4 and 43 nM for ALK6, ALK3 and ALK2, respectively.
It caused a decrease in cell growth and apoptosis of H1299 non-small
cell lung carcinoma cells in vitro.
纯度:≥98%
CAS:1206711-14-9